- Report
- October 2020
- 18 Pages
United Kingdom
From €2850EUR$2,995USD£2,440GBP
- Report
- October 2020
- 18 Pages
China
From €2850EUR$2,995USD£2,440GBP
- Report
- October 2020
- 18 Pages
South Korea
From €2850EUR$2,995USD£2,440GBP
- Report
- October 2020
- 19 Pages
Russia
From €2850EUR$2,995USD£2,440GBP
- Report
- October 2020
- 18 Pages
Brazil
From €2850EUR$2,995USD£2,440GBP
- Report
- October 2020
- 18 Pages
Mexico
From €2850EUR$2,995USD£2,440GBP
- Report
- October 2020
- 18 Pages
Japan
From €2850EUR$2,995USD£2,440GBP
- Report
- May 2023
- 9 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- February 2023
- 11 Pages
Global
From €2997EUR$3,150USD£2,566GBP
- Report
- July 2021
- 11 Pages
Global
From €2854EUR$3,000USD£2,444GBP
- Report
- October 2019
- 99 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- January 2022
- 220 Pages
Global
From €3532EUR$3,712USD£3,024GBP
The Vena Cava Filter market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to prevent pulmonary embolism, a condition in which a blood clot travels to the lungs. Vena Cava Filters are inserted into the inferior vena cava, the largest vein in the body, to capture and prevent the clot from reaching the lungs. The filters are typically made of stainless steel and are designed to be retrievable, allowing for removal once the risk of pulmonary embolism has passed.
The Vena Cava Filter market is driven by the increasing prevalence of deep vein thrombosis, a condition in which a blood clot forms in the deep veins of the body. This is often caused by prolonged immobility, such as during long-distance travel or hospitalization. The market is also driven by the increasing number of minimally invasive procedures, such as laparoscopic surgery, which require the use of Vena Cava Filters.
Notable companies in the Vena Cava Filter market include Boston Scientific, Cook Medical, and Cordis Corporation. Show Less Read more